Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - NOVAVAX INCFinancial_Report.xls
EX-10.4 - EXHIBIT 10.4 - NOVAVAX INCv401319_ex10-4.htm
EX-32.2 - EXHIBIT 32.2 - NOVAVAX INCv401319_ex32-2.htm
EX-23.1 - EXHIBIT 23.1 - NOVAVAX INCv401319_ex23-1.htm
EX-10.5 - EXHIBIT 10.5 - NOVAVAX INCv401319_ex10-5.htm
EX-31.2 - EXHIBIT 31.2 - NOVAVAX INCv401319_ex31-2.htm
EX-10.6 - EXHIBIT 10.6 - NOVAVAX INCv401319_ex10-6.htm
EX-23.2 - EXHIBIT 23.2 - NOVAVAX INCv401319_ex23-2.htm
EX-21.1 - EXHIBIT 21.1 - NOVAVAX INCv401319_ex21-1.htm
EX-31.1 - EXHIBIT 31.1 - NOVAVAX INCv401319_ex31-1.htm
10-K - FORM 10-K - NOVAVAX INCv401319_10k.htm
EX-10.35 - EXHIBIT 10.35 - NOVAVAX INCv401319_ex10-35.htm

 

Exhibit 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT

TO 18 UNITED STATES C. §1350
(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)

 

In connection with the Annual Report of Novavax, Inc. (the “Company”) on Form 10-K for the fiscal period ended December 31, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stanley C. Erck, President and Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:

 

1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the dates and periods covered by this Report.

 

Date: February 27, 2015 By:   /s/ Stanley C. Erck
  President and Chief Executive Officer